Liquidation10779292Private limited companyBromsgrove

RESURGO GENETICS LIMITED

Significant control: Peter John Campbell Clarke (25–50%), Rajiv Gogna (25–50%)

In liquidationThe company is being wound up. A liquidator deals with its affairs, assets and creditors' claims. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Resurgo Genetics Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Resurgo Genetics Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

RESURGO GENETICS LIMITED is a liquidation private limited company (company number 10779292) incorporated on 19 May 2017, registered in Bromsgrove. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.

There are 2,418 companies in research and experimental development on biotechnology in the UK with filed accounts; the median reports net assets of £1,000 and is 7 years old.

Ownership and control

2 active · 1 other

PJ
Mr Peter John Campbell Clarke
Individual · since 19 May 2017
- owns 25–50% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
25–50%
RG
Mr Rajiv Gogna
Individual · since 6 August 2019
- owns 25–50% of shares
25–50%
RG
Mr Rajiv Gogna
Individual · since 19 May 2017 · ceased 28 February 2018
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 19 May 20179 yrs ago
First accounts due: 19 February 20192808 days overdue
Confirmation statement due: 2 June 2027in 217 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Total Exemption Full

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 19 May 2017
Register status is not ActiveLiquidation

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

02 Jun 2027Confirmation statement duein 217 days
19 Feb 2019First accounts due2808 days overdue
19 May 2017Incorporated

Similar companies in Birmingham

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 19 May 2017 · in May 2017.

Reminders for RESURGO GENETICS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.